Hearing on the Horseracing Integrity Act of 2017
January 1, 2019
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Finance Connection
| Candidate | Donor | Amount | Industry | Date |
|---|---|---|---|---|
| FRIENDS OF ANDY BARR COMMITTEE | CLEMENTI, MICHAEL S | $17,000 | PRESIDENT | Mar 2026 |
| FRIENDS OF ANDY BARR COMMITTEE | CLEMENTI, CHRISTOPHER | $17,000 | CEO | Mar 2026 |
| FRIENDS OF ANDY BARR COMMITTEE | PATRICOFF, NELEA | $10,000 | - | Mar 2026 |
| FRIENDS OF ANDY BARR COMMITTEE | PATRICOFF, HAROLD JR. | $10,000 | ATTORNEY | Mar 2026 |
| FRIENDS OF ANDY BARR COMMITTEE | CLEMENTI, JUSTIN | $10,000 | VICE PRESIDENT | Mar 2026 |
| FRIENDS OF ANDY BARR COMMITTEE | AMERICAN MARITIME OFFICERS VOLUNTARY POLITICAL ACTION FUND | $1,000 | - | Mar 2026 |
| FRIENDS OF ANDY BARR COMMITTEE | ABRAMOWITZ, KENNETH | $1,000 | RETIRED | Mar 2026 |
| Alfred Martin | Alfred Martin | $800 | County<br>Commissioner | Mar 2026 |
| Alfred Martin | Alfred Martin | $100 | County<br>Commissioner | Mar 2026 |
Reported financial relationships and timing signals. This does not prove motive or influence. Readers draw their own conclusions.
The Frame
The proposed legislation aimed to shift horseracing regulation from a patchwork of state-level rules to a centralized national standard for medication and drug testing, affecting how racehorses are treated and monitored across the United States.
Potentially affected actors named in the source documents. Mention is not a position.
Thoroughbred horse owners and trainers
The proposed legislation would change the regulatory standards for medication and drug testing they must follow.
State racing commissions
The bill would shift regulatory authority from state-level bodies to a national standard.
Animal welfare organizations
These groups are involved in the debate regarding the ethical treatment and medication of racehorses.
Last recorded activity January 1, 2019.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on June 22, 2018, by the Subcommittee on Digital Commerce and Consumer Protection.
- The primary subject was H.R. 2651, the Horseracing Integrity Act of 2017.
- The bill proposed creating a national, uniform standard for medication and drug testing in the horseracing industry.
- The hearing included testimony from seven witnesses representing industry organizations, racing commissions, and animal welfare groups.
- Several witnesses, including those from the Thoroughbred Horsemen's Association, The Jockey Club, and The Breeders' Cup, provided written statements and answers to follow-up questions.
- The committee record includes supplemental statements from the ASPCA and other submitted documents regarding the bill.
Why It Matters
The proposed legislation aimed to shift horseracing regulation from a patchwork of state-level rules to a centralized national standard for medication and drug testing, affecting how racehorses are treated and monitored across the United States.
Frequently Asked Questions
What was the purpose of this hearing?
Who testified at the hearing?
News Coverage
Sponsors
Show 3 more sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Centralization of Racing Regulation
The hearing highlights a clear legislative push to move from state-based regulation to a federal, uniform standard for horse medication.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools